ARTICLE | Company News
NICE rebuffs Afinitor again
November 30, 2010 12:13 AM UTC
The U.K.'s NICE issued a second final appraisal determination (FAD) recommending against use of Afinitor everolimus from Novartis AG (NYSE:NVS; SIX:NOVN) for second-line treatment of advanced renal c...